Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7334)
All Articles published online
|
Publishing Process of This Article
|
Dec 10, 2017 (publication date) through Nov 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Rabanal C, Ruiz R, Neciosup S, Gomez H. Metronomic chemotherapy for non-metastatic triple negative breast cancer: Selection is the key. World J Clin Oncol 2017; 8(6): 437-446 [PMID: 29291168 DOI: 10.5306/wjco.v8.i6.437] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v8/i6/437.htm |
| Number | Citing Articles |
| 1 |
Lili Huang, Ting Jiang, Pengcheng Li, Jie Zhang, Xing Luo, Fang Yang, Tao Ren, Ke Xu. Effectiveness and toxicity of metronomic oral cyclophosphamide for recurrent or platinum-refractory ovarian cancer: A meta-analysis. Heliyon 2022; 8(8): e10399 doi: 10.1016/j.heliyon.2022.e10399
|
| 2 |
Yufei Wang, Guochao Zhang, Jie Han. HIF1A‐AS2 predicts poor prognosis and regulates cell migration and invasion in triple‐negative breast cancer. Journal of Cellular Biochemistry 2019; 120(6): 10513 doi: 10.1002/jcb.28337
|
| 3 |
Yueyue Wang, Lei Yan, Lingyu Zhang, Henan Xu, Tiantian Chen, Yu Li, Haifeng Wang, Sulian Chen, Wenrui Wang, Changjie Chen, Qingling Yang. NT21MP negatively regulates paclitaxel-resistant cells by targeting miR‑155‑3p and miR‑155-5p via the CXCR4 pathway in breast cancer. International Journal of Oncology 2018; doi: 10.3892/ijo.2018.4477
|
| 4 |
Qi-Yuan Huang, Guo-Feng Liu, Xian-Ling Qian, Li-Bo Tang, Qing-Yun Huang, Li-Xia Xiong. Long Non-Coding RNA: Dual Effects on Breast Cancer Metastasis and Clinical Applications. Cancers 2019; 11(11): 1802 doi: 10.3390/cancers11111802
|
| 5 |
Gonçalo N. Petrucci, Joaquim Henriques, Luís Lobo, Hugo Vilhena, Ana C. Figueira, Ana Canadas‐Sousa, Patrícia Dias‐Pereira, Justina Prada, Isabel Pires, Felisbina L. Queiroga. Adjuvant doxorubicin vs metronomic cyclophosphamide and meloxicam vs surgery alone for cats with mammary carcinomas: A retrospective study of 137 cases. Veterinary and Comparative Oncology 2021; 19(4): 714 doi: 10.1111/vco.12660
|
| 6 |
Weili Liang, Shasha Song, Yintao Xu, Huiying Li, Huantao Liu. Knockdown of ZEB1 suppressed the formation of vasculogenic mimicry and epithelial-mesenchymal transition in the human breast cancer cell line MDA-MB-231. Molecular Medicine Reports 2018; doi: 10.3892/mmr.2018.8677
|
| 7 |
Yunfeng Liu, Yanping Zhong, Wei Tian, Fu Lan, Jiankang Kang, Huifeng Pang, Huaxin Hou, Danrong Li. An autophagy-dependent cell death of MDA-MB-231 cells triggered by a novel Rhein derivative 4F. Anti-Cancer Drugs 2019; 30(10): 1038 doi: 10.1097/CAD.0000000000000820
|
| 8 |
Farshad Moradi Kashkooli, M. Soltani. Evaluation of solid tumor response to sequential treatment cycles via a new computational hybrid approach. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-00989-x
|
| 9 |
Tasaduq Hussain Wani, Goutam Chowdhury, Anindita Chakrabarty. Generation of reactive oxygen species is the primary mode of action and cause of survivin suppression by sepantronium bromide (YM155). RSC Medicinal Chemistry 2021; 12(4): 566 doi: 10.1039/D0MD00383B
|
| 10 |
Amitha Muraleedharan, Sagar Kumar, Rashmi Mittal. Therapeutic Drug Targets and Phytomedicine For Triple Negative Breast Cancer. 2023; : 73 doi: 10.2174/9789815079784123010007
|
| 11 |
Man Guo, Ruoyan Wang, Mandi Nie, Hao Zhang, Cao Wang, Chunfeng Song, Shurun Niu. H3K27ac-induced RHOXF2 activates Wnt2/β-catenin pathway by binding to HOXC13 to aggravate the malignant progression of triple negative breast cancer. Cellular Signalling 2024; 120: 111196 doi: 10.1016/j.cellsig.2024.111196
|
| 12 |
Shuang Ye, Yuanyuan Xu, Jiehao Li, Shuhui Zheng, Peng Sun, Tinghuai Wang. Prognostic role of GPER/Ezrin in triple-negative breast cancer is associated with menopausal status. Endocrine Connections 2019; 8(6): 661 doi: 10.1530/EC-19-0164
|
| 13 |
Jia Fu, Wenpan Li, Xiu Xin, Dawei Chen, Haiyang Hu. Transferrin-Modified Nanoliposome Codelivery Strategies for Enhancing the Cancer Therapy. Journal of Pharmaceutical Sciences 2020; 109(8): 2426 doi: 10.1016/j.xphs.2019.11.013
|
| 14 |
Gonçalo Petrucci, Joaquim Henriques, Hugo Gregório, Gonçalo Vicente, Justina Prada, Isabel Pires, Luís Lobo, Rui Medeiros, Felisbina Queiroga. Metastatic feline mammary cancer: prognostic factors, outcome and comparison of different treatment modalities – a retrospective multicentre study. Journal of Feline Medicine and Surgery 2021; 23(6): 549 doi: 10.1177/1098612X20964416
|
| 15 |
Chen Gong, Jin Zou, Mingsheng Zhang, Jie Zhang, Shanshan Xu, Siqi Zhu, Mengqi Yang, Dongjia Li, Yun Wang, Jialu Shi, Yong Li. Upregulation of MGP by HOXC8 promotes the proliferation, migration, and EMT processes of triple‐negative breast cancer. Molecular Carcinogenesis 2019; 58(10): 1863 doi: 10.1002/mc.23079
|
| 16 |
Shantanu Pradhan, John L. Sperduto, Cindy J. Farino, John H. Slater. Engineered In Vitro Models of Tumor Dormancy and Reactivation. Journal of Biological Engineering 2018; 12(1) doi: 10.1186/s13036-018-0120-9
|